Regulation of Ubiquitination and Arthritis
Regulation of Ubiquitination and Arthritis
批准号:
9919373
负责人:
AVERIL I MA
金额:
$40.33万
依托单位国家:
美国
项目类别:
财政年份:
2018
资助国家:
美国
项目状态:
已结题
起止时间:
2018-05-05 至 2023-04-30
关键词:
AblationAgeAntibodiesArthritisAutoimmunityBindingBiochemicalCellsChronicCleaved cellComplementComplexCysteineDataDendritic CellsDevelopmentDiseaseDissectionEpigenetic ProcessExperimental ModelsFunctional disorderFutureGenetic EpistasisGoalsHomeostasisHumanHuman GeneticsImmuneImmune responseImmune signalingImmunologicsIn VitroInflammasomeInflammatoryInflammatory ArthritisInterleukin-1Interleukin-17JointsKnock-inKnock-in MouseKnockout MiceLeadLigandsLigaseLinkMediatingMolecularMouse StrainsMusMutant Strains MiceMutationPainPathway interactionsPatientsPenetrancePhenotypePhysiologicalPoint MutationPredispositionProteinsPsoriatic ArthritisRIPK1 geneRegulationRheumatismRheumatoid ArthritisRoleSeriesSignal PathwaySignal TransductionSpondylarthritisStudy modelsSyndromeTNF geneTNFSF11 geneTRAF6 geneTestingTherapeuticTumor Necrosis Factor ReceptorUBD proteinUbiquitinUbiquitinationZinc Fingersbasedisabilityexperimental studygenetic variantimproved outcomein vivoinsightjoint injurymacrophagemouse modelneutrophilnovel therapeuticspreservationpreventrecruitresponseubiquitin-protein ligase
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary/Abstract
Arthritides are chronic, progressive systemic inflammatory diseases that lead to significant joint damage, pain,
dysfunction, and disability. A20, also known as TNFAIP3, is genetically and epigenetically linked to human
arthritis, and recent experimental studies implicate A20 in regulating several potential pathophysiological
arthritis pathways. Mice bearing A20 deficient dendritic cells or A20 deficient macrophages/neutrophils
spontaneously develop arthritis. A20 restricts several inflammatory pathways, including TLR, TNFα, and
inflammasome signals. How A20 performs these critical functions and prevents arthritis are poorly understood.
A20 has multiple motifs that mediate deubiquitinating, ubiquitin binding, and E3 ubiqutin ligase activities. The
goal of this proposal is to understand the biochemical mechanisms by which A20 prevents arthritis. We have
generated several knock-in lines of mice with strategic point mutations that abrogate specific biochemical
functions of A20. Using these new mouse strains, we will determine which of A20's ubiquitin dependent
functions preserve the cellular and molecular pathways that prevent arthritis. The proposed studies will
establish a new robust mouse model of spontaneous arthritis based on a human arthritis susceptibility protein.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Ubiquitination, Intestinal Homeostasis and Cancer
-
批准号:10522777
-
项目类别:
-
资助金额:$44.86万
-
财政年份:2022
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitination, Intestinal Homeostasis and Cancer
-
批准号:10685627
-
项目类别:
-
资助金额:$43.96万
-
财政年份:2022
-
负责人:AVERIL I MA
-
依托单位:
Regulation of Ubiquitination and Arthritis
-
批准号:10399464
-
项目类别:
-
资助金额:$40.38万
-
财政年份:2018
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8638002
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8829675
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8321633
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
A20 Mediated Regulation of Colitis and Spondyloarthritis
-
批准号:8436190
-
项目类别:
-
资助金额:$32.43万
-
财政年份:2012
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:8363762
-
项目类别:
-
资助金额:$0.0万
-
财政年份:2011
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:8169756
-
项目类别:
-
资助金额:$0.18万
-
财政年份:2010
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:8007517
-
项目类别:
-
资助金额:$9.86万
-
财政年份:2010
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7957395
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2009
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7724203
-
项目类别:
-
资助金额:$0.66万
-
财政年份:2008
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7601849
-
项目类别:
-
资助金额:$0.03万
-
财政年份:2007
-
负责人:AVERIL I MA
-
依托单位:
UBIQUITYLATION AND THE REGULATION OF IMMUNE HOMOSTASIS
-
批准号:7369092
-
项目类别:
-
资助金额:$1.38万
-
财政年份:2006
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7484193
-
项目类别:
-
资助金额:$43.89万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7493167
-
项目类别:
-
资助金额:$8.3万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7117352
-
项目类别:
-
资助金额:$43.68万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:6957143
-
项目类别:
-
资助金额:$42.07万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7920534
-
项目类别:
-
资助金额:$5.72万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
Ubiquitylation and the Regulation of Immune Homeostasis
-
批准号:7265100
-
项目类别:
-
资助金额:$43.6万
-
财政年份:2005
-
负责人:AVERIL I MA
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: